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Introduction
The demographics of the UK population have changed 
significantly in the last four to five decades, with the most 
notable changes being increased life expectancy resulting in 
an ageing population. As a result of this progressively ageing 
population, there is an increasing prevalence of dementia. 
The prevalence of dementia increases dramatically with 
advancing age; for example, it rises from 1.7% of people 
aged between 65 and 69 years to affect more than 40% of 
people over the age of 95 years (Prince et al. 2014). It has 
been estimated that the total number of people in the UK with 
some form of dementia ranges from 670 000 (Matthews et 
al. 2013) to 835 000 (Prince et al. 2014). One million people 
in the UK are predicted to have dementia by 2025, a figure 
that is likely to rise to over 2 million by 2051 (Alzheimer’s 
Society 2017). Although the prevalence of dementia is higher 
in the elderly population, dementia is not exclusively a 
disease of older people, and there are approximately 
42 000 people in the UK younger than 65 years who have this 
condition (Alzheimer’s Society 2017). 
Figure 1 illustrates how the most rapid UK population growth 
is in people aged 85 years and over, often referred to as 
the ‘oldest old’. Between 1985 and 2010 the percentage of 
the population aged 85 and over increased from 1% to 2%, 
with the numbers aged 85 and over more than doubling 
from nearly 0.7 million to reach over 1.4 million by 2010. 
By 2035 it is projected that the number of people aged 85 
and over will be almost 2.5 times larger than in 2010, 
reaching 3.5 million and accounting for 5% of the total UK 
population. In comparison, the population growth in the 
over-65-year-olds is more modest, predicted to increase by 
approximately 50% between 1985 and 2035.
 
Per cent
Figure 1. How the proportion of the UK population aged 
65 years and older and 85 years and older has changed 
and is predicted to change over five decades between 
1985 and 2035.
Dementia is defined as ‘a major degenerative disorder with 
evidence of substantial cognitive decline from a previous 
level of performance in one or more domains such as 
short-term memory, abstract thinking, judgment, language, 
and personality changes sufficiently severe to interfere 
with independence’ (American Psychiatric Association 
2013). Rather than a single symptom or sign, the term 
dementia describes a set of symptoms/signs that may include 
memory loss, impaired reasoning, language, communication, 
judgement and loss of coordination. There are many 
different types of dementia, with Alzheimer’s disease being 
the most common and well known. Other main types include 
vascular dementia and dementia with Lewy bodies (DLB). 
Figure 2 illustrates the relative frequency of the main forms 
of dementia, based on data from Dementia UK: Update 
(Prince et al. 2014).
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Figure 2. Relative frequency of the main types of 
dementia in the UK. Data from Prince et al. (2014).
Alzheimer’s disease, which is a progressive condition, 
currently affects more than 520 000 people in the UK. During 
the course of the disease, proteins build up in the brain to 
form structures called amyloid plaques and neurofibrillary 
tangles. This leads to the loss of connections between 
nerve cells, and eventually to nerve cell death and loss of 
brain tissue.
Vascular dementia is the second most common type 
of dementia, affecting around 150 000 people in the UK. In 
vascular dementia, symptoms of memory loss and difficulties 
with thinking, problem solving or language occur when the 
brain is damaged as a result of impaired blood supply. 
Dementia with Lewy bodies is a type of dementia that shares 
symptoms with both Alzheimer’s disease and Parkinson’s 
disease. In addition to problems with attention and 
alertness, patients with DLB frequently experience visual 
hallucinations (seeing things that are not there), usually in 
the early stages of the condition. Visual hallucinations can 
occur daily, last several minutes and can be very distressing 
for the patient as they are detailed and convincing to the 
person with dementia. Finally, mixed dementia is a 
combination of Alzheimer’s disease and vascular dementia. 
Optometrists frequently encounter patients with dementia 
during primary care eye examinations conducted in both 
practice and domiciliary settings, and in the hospital eye 
service. Providing domiciliary eye care to people with 
dementia, either in their own homes or in care homes, is 
becoming an increasingly important aspect of community 
eye care. Approximately two-thirds of people with dementia 
live in private households and the remaining one-third live 
in some form of institutional care setting (Matthews et al. 
2013). Many older people with sight loss live in care 
homes and there is some evidence that they are subject 
to a disproportionately high burden of visual loss, with an 
estimated 30% of those who are visually impaired in the UK 
living in care homes (Evans and Wormald 2011).
 
An estimated 1.87 million people live with sight loss in the 
UK. Approximately 360 000 are registered as sight-impaired 
or severely sight-impaired (Access Economics 2009). Ninety 
per cent of new cases of permanent sight loss in the UK 
in 2016–2017 occurred in people aged 65 years or older 
(Deloitte Access Economics 2017). Age-related macular 
degeneration is by far the main cause of registrable visual 
impairment (VI) (sight-impaired or severely sight-impaired) 
in the adult UK population (Bunce and Wormald 2006). Other 
major causes are diabetic eye disease and glaucoma (Jonas 
et al. 2017). However, an estimated 1.64 million of those in 
the UK with sight loss have mild or moderate loss, much 
of which is correctable (RNIB 2013). The main causes of 
correctable visual loss are cataract and uncorrected or 
undercorrected refractive error (Evans and Rowlands 2004; 
Evans and Wormald 2011). 
Dementia and sight loss develop independently, but both 
dementia and the major causes of sight loss are age-related. 
Therefore, with our progressively ageing population there is 
an increased risk of developing dementia and having serious 
sight loss concurrently (RNIB and Age UK 2015), resulting in an 
increased demand for eye care, which frequently is provided 
in a domiciliary setting. In 2015–2016, 3.3% of NHS sight 
tests were domiciliary examinations, conducted in the 
individual’s place of residence or at a day centre (Health and 
Social Care Information Centre 2016). Anyone eligible for an 
NHS sight test qualifies for a domiciliary sight test if they 
are unable to attend a high-street practice unaccompanied 
due to a physical or mental illness or disability (Optical 
Confederation 2015). 
The number of domiciliary sight tests has risen steadily over 
the last 10 years, from around 310 000 in 2006–2007 to over 
430 000 in 2015–2016, an increase of approximately 40% 
compared with a decade earlier. This increase could be 
attributed to the ageing UK population, with older people 
seeking eye examinations in their own home, although there 
is no direct evidence to support this (Health and Social Care 
Information Centre 2016).
Visual problems in dementia
Visual problems in dementia include loss of visual acuity, 
defects in colour vision, changes in pupillary response to 
mydriatics, defects in fixation and smooth and saccadic eye 
movements, changes in contrast sensitivity function and 
visual evoked potentials and disturbance of complex visual 
functions such as reading ability, visuospatial function and 
the naming and identification of objects. Detailed discussion 
of these and other visual deficits that can occur in dementia, 
which is beyond the scope of this article, can be found in the 
excellent and well-referenced review article by Armstrong 
and Kergoat (2015). 
These problems may affect different aspects of visual 
performance and reduced contrast sensitivity, impaired 
motion detection, impaired stereopsis and difficulty 
recognising faces, objects and colour can result in the person 
with dementia experiencing difficulties with orientation. As 
a consequence, people with dementia experience symptoms 
such as bumping into things, getting lost in familiar 
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surroundings and misinterpreting reflections. One potentially 
disturbing phenomenon, which can occur when viewing 
themselves in a mirror, is that people with dementia may not 
recognise themselves at all (Chandra and Issac 2014) or see 
a much younger version of themselves. 
Optometrists working in both primary and secondary care 
will often examine people with dementia before a formal 
diagnosis has been made. This is due in part to visually related 
symptoms, such as difficulty in reading, not recognising 
familiar objects and spatiotemporal disorientation, which 
may develop early on in people with dementia (Cogan 1985; 
Mendez et al. 1990), leading them to consult an optometrist 
in the first instance rather than their GP (Armstrong and 
Kergoat 2015). Studies investigating sight loss and dementia 
have revealed shared changes in nervous system physiology 
and suggest that the prevalence of sight loss in people with 
dementia is higher than that in the general population of 
older people without dementia (Jones and Martin 2007).
The Prevalence of Visual Impairment in 
people with Dementia (PrOVIDe) study
Although VI and dementia often coexist, until recently there 
has been little UK prevalence data on VI among people 
with dementia. The PrOVIDe study was a large-scale 
England-wide study undertaken by a multidisciplinary 
team led by the College of Optometrists and funded by the 
National Institute for Health Research. 
The study was carried out in two stages. In stage 1, a total 
of 708 people with dementia, aged 60–89 years, underwent 
a domiciliary sight test complying with General Ophthalmic 
Services requirements and professional guidelines. The sample 
included people living in their own homes (n = 389) or in 
care homes (n = 319). In stage 2 qualitative data were collected 
from 119 participants using interviews with people with 
dementia, and interviews and focus groups with family 
carers, professional care workers and optometrists. The study 
findings have been published in full by the National Institute 
for Health Research (Bowen et al. 2016).
The key objectives of the PrOVIDe study were to measure 
the prevalence of eye conditions causing VI in people 
with dementia and to identify and/or describe reasons for 
underdetection or inappropriate management of these 
conditions. A total of 708 participants with dementia had 
domiciliary eye examinations conducted by a team of 
research optometrists from The Outside Clinic who were 
experienced in examining people with dementia. The 
optometrists were able to perform an eye examination, 
although not necessarily a full eye examination, on all 
participants living in their own homes (group 1: n = 389, 
median age = 80 years) and most of the participants living 
in care homes (group 2: n = 319, median age = 83 years). 
Optometrists were unable to perform any part of the eye 
examination on eight participants, all of whom lived in 
care homes. All participants had their level of cognitive 
impairment assessed with a frequently used and validated 
test, the standardised Mini Mental State Examination (sMMSE). 
This allowed the researchers to identify any significant 
correlations between the ability of participants to complete 
various elements of the eye examination and their level of 
cognitive impairment.
A variety of definitions of VI have been used in prevalence 
studies. All of these definitions use criteria for VI based 
on levels of visual acuity (VA) as recorded on Snellen 
progression VA charts. The two cut-off points most 
commonly used to define VI in terms of VA are: (1) VA <6/12 
Snellen (0.32 logMAR equivalent) (National Eye Institute 
2017) and (2) VA <6/18 Snellen (0.48 logMAR equivalent) 
(Department of Health 2017). 
The prevalence of visual impairment
For the PrOVIDe study VI was subdivided into:
• Presenting VI: participants were visually impaired whilst 
wearing their current distance spectacles or unaided if no 
spectacles were worn for distance vision.
• Postrefraction (or best-corrected) VI: the participant 
was visually impaired whilst wearing the prescription 
determined by the PrOVIDe optometrist.
• Uncorrected or undercorrected VI: these participants 
had presenting VI but were not visually impaired 
when wearing the prescription determined by the 
PrOVIDe optometrist.
When looking at the effects of the participants’ place of 
residence, the prevalence of VI of all three types described 
above was approximately 2–2½ times more common for 
those participants living in care homes compared to those 
living in their own homes. It could be argued that this 
difference could be attributed to care home residents being 
older and more cognitively impaired than those living in their 
own homes. However, after controlling statistically for age, 
gender and level of cognitive impairment (sMMSE score), 
the prevalence of uncorrected or undercorrected VI was still 
found to be statistically significantly greater for those 
participants living in care homes. Full prevalence data can be 
found in the published PrOVIDe report (Bowen et al. 2016). 
For those participants in whom we found postrefraction VI, 
one single cause for VI was identified for each participant. 
Cataract was the primary cause of almost 50% of VI with 
VA <6/12 and is potentially remediable with cataract 
surgery. Age-related macular degeneration was the primary 
cause of VI in approximately one-third of participants with 
VA <6/12. For VA <6/18, these proportions were reversed, 
with age-related macular degeneration being the cause 
of VI in almost 50% of cases and cataract the cause in 
approximately one-third of cases.
A secondary objective of the study was to determine the 
proportions of the sample who were able to complete key 
elements of a routine eye examination. These results are 
shown in Table 1. Most key tests were possible in over 80% 
of participants. Participants who were unable to complete the 
key tests were significantly more likely to live in care homes 
and were significantly more cognitively impaired. 
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One, perhaps surprising, finding that emerged from the 
PrOVIDe study focus groups and interviews was that virtually 
all of the study participants living at home, and their carers, 
were unaware that domiciliary sight tests were available 
to people unable to attend an optometric practice 
unaccompanied. We have previously made recommendations 
for a dementia eye care pathway (DECP) (Hancock et al. 
2015); however this pathway has not yet been adopted. One 
recommendation was that, when a diagnosis of dementia 
was made by a GP or old-age psychiatrist, the individual 
and carer(s) should receive written information regarding 
the importance of regular eye examinations, a measure 
which should reduce the prevalence of VI in people 
with dementia and the considerable impact of VI on an 
individual’s quality of life. It was recommended that part of 
the core information provided through the DECP should 
be information about how to access a domiciliary service 
if required. 
Although our DECP recommendations have not been 
adopted, the College of Optometrists’ Guidance for 
Professional Practice (College of Optometrists 2014a) states 
that ‘If you do not offer a domiciliary service you, or your 
practice, should make information available about where 
patients can access these services’. Providing this information 
is particularly important for patients with dementia or 
cognitive impairment as they may be unable to attend an 
optometric practice unaccompanied.
The eye examination and dementia
Becoming a Dementia Friend
The Dementia Friends programme (www.dementiafriends. 
org.uk) is an Alzheimer’s Society initiative run by the 
Alzheimer’s Society and Public Health England. It is the biggest 
ever initiative to transform people’s perceptions of dementia 
and aims to educate the public on what it is like to live with 
dementia, on ways in which one can help and support those 
living with dementia and how to ‘make a difference’. Anyone 
can become a Dementia Friend by watching a short online 
video or by attending a face-to-face information session. 
There are currently over 2 million Dementia Friends. With 
the current ageing population and with approximately one 
in six people over the age of 80 currently being affected 
by dementia, optometrists and practice staff will benefit 
from this additional training to help them confidently 
support those dementia patients and their carers who attend 
their practice. 
In addition, there is scope to become a Dementia Friends 
Champion – a volunteer who encourages others to make a 
positive difference to people living with dementia in their 
community. Dementia Friends Champions can attend an 
induction, receive support as required and be part of a 
group of volunteers creating a dementia-friendly community. 
The overall objective of Dementia Friends is to build a 
dementia-friendly society, and optometry has a role to play 
here by creating more dementia-friendly practices which 
are sympathetic to the needs of people with dementia and 
their carers.
Improve expertise in examining people with 
dementia
The College of Optometrists’ updated Guidance for 
Professional Practice has a section ‘Examining patients 
with dementia or other acquired cognitive impairment’. 
This contains very valuable advice for practitioners (College 
of Optometrists 2014b). The sections on ‘The domiciliary 
eye examination’ and ‘Consent’ are particularly relevant 
to eye examinations on people with dementia (College of 
Optometrists 2014c, d). The College of Optometrists has 
a recommended reading list for improving expertise in this 
field and has included ‘Dementia and the eye examination’ 
and an ‘Optometry and dementia lecture video’ in its online 
learning section on dementia.
Optometrists who took part in the focus groups held as 
part of the PrOVIDe study felt that the best and quickest 
way to gain expertise in examining patients with dementia 
was to shadow another optometrist who is experienced in 
examining dementia patients (Bowen et al. 2016). 
Prepare for the appointment
Raising awareness amongst colleagues within the practice 
setting, ideally with colleagues becoming Dementia Friends, 
would ensure that appropriate preparations are made for the 
optimal examination of a patient with dementia. Provided 
the practice staff are made aware that the patient has 
dementia when the appointment is made, they can advise 
Table 1. Table showing the ability to carry out key elements of the eye examination in people with dementia
Percentage able to carry out test
Eye examination element Full sample Group 1 (own home) Group 2 (care home)
Objective assessment of refractive error 88.1% 92.0% 83.4%
Subjective assessment of refractive error 80.9% 95.1% 63.6%
Visual acuity measurement 83.2% 97.4% 65.8%
Tonometry 94.8% 99.2% 89.3%
Fundus examination 91.2% 97.4% 83.7%
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Upon completion of the eye examination, the optometrist 
should provide advice on the findings of the examination 
to the patient, relative or carer as appropriate and with the 
patient’s consent. This information should be given in a 
way that is easy to understand, and could take the form of 
a short written report, reassuring the patient about visual 
function and absence of abnormal findings (College of 
Optometrists 2014e). When examining a patient who is 
severely cognitively impaired in the absence of a relative 
and/or carer, the optometrist should at all times act in the 
best interest of the patient. It is good practice to consider 
writing a report of your findings to the patient’s GP, leaving a 
copy with the patient.
Flexible and adaptable
When examining patients with dementia, it is important for 
optometrists to be flexible and adaptable such that their 
routine is influenced by the cognitive ability of the patient. 
For patients who have moderate to severe cognitive 
impairment, the optometrist may need to concentrate 
on objective rather than subjective tests. The College of 
Optometrists’ guidance for professional practice stresses 
this need for the optometrist to be flexible during the 
examination, adapting techniques and using alternative 
appropriate methods (College of Optometrists 2014b). 
The PrOVIDe study research optometrists examined 
patients in accordance with these guidelines and were able 
to conduct four key tests (retinoscopy, subjective refraction, 
direct ophthalmoscopy and tonometry) in over 80% of 
participants examined in this study.
Patients with dementia may take longer to process the 
question they are being asked and therefore are slower in 
their response. It is important to bear this in mind when 
arranging the eye examination. A longer than normal 
appointment may be beneficial or it may be preferable to 
split the appointment over two visits rather than one for 
this patient group, although the current General Ophthalmic 
Services funding structure in England does not allow for this 
(Hancock et al. 2015). It may not be possible to complete all 
elements of the eye examination in patients with moderate 
or severe cognitive impairment. Any limitations to the eye 
examination, omission of tests and results obtained should be 
accurately recorded (College of Optometrists 2014b).
Consent and capacity
Capacity to consent in England is governed by the Mental 
Capacity Act (2005). When referring to capacity to consent 
in the context of the eye examination, this includes having 
dilating drops instilled and performing various elements of 
the eye examination such as tonometry. Patients’ ability to 
make decisions may depend on the nature and severity of 
their cognitive impairment, or the difficulty or complexity of 
the decision. Healthcare professionals must assess patients’ 
capacity to make an informed decision about the treatment 
and then assess if they are able to decide whether to have 
the treatment. In doing so, the optometrist must also be 
aware that a patient’s capacity to consent may vary and this 
may require the need to reassess the patient on another 
occasion (College of Optometrists 2014e). Before the eye 
examination, the optometrist could ask the patient if there 
the optometrist regarding the patient’s cognitive impairment 
prior to the examination taking place. This avoids the all 
too common occurrence of the optometrist not realising 
that the patient has dementia until some point during the 
examination. When the appointment is made, it is important 
to bear in mind factors such as the best time of day for the 
patient (both in a practice or domiciliary setting), whether 
the patient is likely to need additional time for the 
examination and whether any special arrangements are 
required when the patient attends. It is worth discussing 
with patient and/or carer whether the patient may benefit 
from an examination in a domiciliary setting as they may not 
be aware of this option.
Involve carer/care worker
Optometrists in focus groups in the PrOVIDe study found 
it beneficial to involve an informed carer at all stages of the 
examination. If the practice is made aware at the time of 
arranging the appointment that the patient has dementia, 
the optometrist can speak with the carer to establish the 
patient’s level of cognitive impairment, cooperation and 
ability to consent before the appointment.
Having an informed carer present during the examination 
provides reassurance to the patient. Using data gathered 
from the PrOVIDe study, the presence or absence of a 
carer was analysed for its contribution to successful or 
unsuccessful completion of five key elements of the 
eye examination. These were objective assessment of 
refractive error, subjective assessment of refractive error, VA 
measurement, fundus examination by ophthalmoscopy and 
tonometry. This analysis concluded that the presence of a 
carer was associated with a statistically significant positive 
impact on the ability of the participant to complete VA 
measurement successfully. For the other four tests, the 
impact of the carer was also positive but failed to reach 
statistical significance. It is important to establish how 
well the carer knows the patient at the outset because it 
is possible that the professional carer attending the eye 
examination may not be very familiar with the patient’s 
case. The optometrist should record the name of the carer 
who was present during the examination on the patient’s 
record card.
Patience and communication
Patients with moderate or severe cognitive impairment 
often take time to understand and process the questions 
they are asked and the information that is being given to 
them. When communicating with patients with dementia, it 
is important to slow down and perform the eye examination 
at the pace that is appropriate for the patient, so that 
patients can follow and respond to what is being required of 
them. The College of Optometrists’ guidance for professional 
practice, in the section on ‘Communicating with patients 
effectively’ (College of Optometrists 2014e), states that 
optometrists should communicate with patients in a way 
that they can understand. Additionally, irrespective of 
their level of cognitive impairment, mental capacity and 
ability to consent, it is important to include patients in all 
discussions and decisions about their management, treatment 
and ongoing care as fully as possible.
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were any tasks (vision-related) that the patient found 
particularly difficult. If the patient is unable to respond 
appropriately, the optometrist could consider speaking 
with the carer and/or care home staff to help establish the 
cognitive and other abilities of the patient.
The College of Optometrists’ guidance for professional 
practice has an excellent section on consent and a 
subsection on Capacity to Consent – Adults (College of 
Optometrists 2014d), which states we must regard patients 
as lacking capacity only once it is clear that, having been 
given all the appropriate help and support, they cannot 
understand, retain, use or weigh up the information needed 
to make a decision or communicate their wishes (College of 
Optometrists 2014e).
 
Finally, any decisions or actions taken on behalf of the 
patient who lacks capacity should be in the patient’s best 
interests. It is good practice to keep an accurate record of 
all discussions with the patient and carer, record the name 
of the carer present during the examination on the patient’s 
record card and write a report of your findings to leave with 
the patient and carer.
Equipment
When examining patients with dementia, it is important 
to select the optimal equipment to use during the eye 
examination. For example, use of a computerised test chart 
would be advantageous because of the different chart styles 
available (eg Snellen, logMAR, symbols, Kay pictures) and 
the ease and ability to present single letters. Patients with 
dementia are known to have problems with mirrors, and 
computerised test charts are ideal when examining this 
patient group because they can be used without a mirror. 
Computerised charts are also useful in a domiciliary 
setting where adjustments may be required based on the 
viewing distance. In the PrOVIDe study it was possible to 
measure distance VA in 83.2% of participants when using a 
computerised test chart (Bowen et al. 2016). 
Research optometrists who helped with the data collection 
in the PrOVIDe study all felt the Icare tonometer (Icare 
Finland Oy, Vantaa, Finland) was ideal for intraocular pressure 
measurements in dementia patients (Bowen et al. 2016). 
The Icare uses a contact technique that can be performed 
without the use of a topical anaesthetic. A comparison 
between the Icare tonometer and the Goldmann applanation 
tonometer (Haag Streit, Bern, Switzerland), the current 
reference standard method for measuring intraocular pressure, 
concluded that there is good agreement between the two 
methods of intraocular pressure measurement. In addition, 
the Icare tonometer is easy to use and records consistent 
readings rapidly, with minimal training required (Pakrou et al. 
2008). Tonometry, using the Icare tonometer, was possible 
in almost 95% of all participants in the PrOVIDe study 
(Bowen et al. 2016). The importance of tonometry in older 
people suspected of having dementia is reinforced by the 
increasing prevalence of glaucoma with age; for example, 
rising from 0.4% in white populations aged 40–49 years to 
3.3% in those aged 70–79 years (Rudnicka et al. 2006).
Whilst dilated fundus examination is optimal for detection 
of eye disease, it may not be possible on all patients with 
dementia. A total of 67% of all participants were dilated in 
our study, 81% of those living in their own homes and 51% 
of those living in care homes.
Prescribing spectacles
When prescribing spectacles generally, as optometrists, we 
aim to keep clinical changes in prescription to a minimum, 
often following the ‘if it ain’t broke, don’t fix it’ prescribing 
maxim (Elliott and Howell-Duffy 2015). When prescribing 
and dispensing new spectacles to people with dementia, it 
is even more important to keep unnecessary changes to a 
minimum because patients with dementia do not cope well 
with change of any sort. For example, any change in the 
type of lenses (eg separate pairs for distance and near 
vision, bifocal, progressive-power lenses) or frames (eg style 
and colour) used in previous spectacles may be confusing 
and contribute to a refusal by the patient to wear the new 
spectacles. If the frames look and feel the same, the patient 
is more likely to wear them. It is worth also bearing in mind 
that large changes in prescription in all older people can 
affect their mobility and increase the likelihood of falls 
(Elliott et al. 2017).
Missing and broken spectacles were another issue that was 
reported to be common in care homes (Bowen et al. 2016). 
Labelling spectacles with the wearer’s name, date of supply 
and purpose (eg for distance or near tasks) facilitates the 
return of spectacles to the rightful owner (College of 
Optometrists 2014b). Carers can also benefit from the 
optometrist providing a brief report that includes the 
person’s visual problems, the purpose of the spectacles 
and a recommended date for re-examination (Rashid and 
Sheppard 2013). Labelling current spectacles with names and 
functions would also assist optometrists when they carry 
out an eye examination. Despite these efforts, some people 
with dementia will refuse to wear any spectacles. These 
individuals may be helped by the simple measures of making 
things ‘bigger, brighter or bolder’, eg by sitting closer to the 
television or using improved lighting.
Advice to practitioners
Results from the PrOVIDe study show it was possible 
for optometrists to conduct key components of the eye 
examination on >80% of people with dementia. Tailoring 
the eye examination and spectacle dispensing is necessary to 
meet the needs of patients with dementia. Top tips for 
optometrists examining patients with dementia are:
• Make your practice dementia-friendly by becoming a 
Dementia Friend and having a Dementia Friends Champion 
in the practice.
• Improve your expertise in examining people with 
dementia using online videos, College of Optometrists’ 
guidance and shadowing an optometrist with expertise 
in this area.
• Prepare for the appointment by asking practice staff 
to inform you when they have booked in a patient 
with dementia and speaking to a carer before the 
appointment.
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• Involve an informed carer at every stage of the eye 
examination and obtain pre-appointment advice on the 
degree of cognitive impairment, capacity and likely level 
of cooperation.
• Be patient and concentrate on communication whilst 
allowing additional time for patient responses.
• Be flexible and adaptable in your approach by adapting 
your routine to the patient’s cognitive ability.
• Consider capacity and consent: the patient’s ability to 
make decisions may depend on the nature and severity 
of the cognitive impairment, or the difficulty or 
complexity of the decision.
• Choose suitable equipment, eg computerised test chart 
and Icare tonometer.
• When prescribing spectacles, it is important to pay 
additional attention to ascertaining what activities are 
important to the patient, allowing the optometrist, 
patient and/or carer to arrive at clear shared objectives 
for correcting vision whilst bearing in mind the maxim 
‘if it ain’t broke, don’t fix it’. This advice applies to both 
spectacles and lens type.
• Label spectacles with the name of the patient, date of 
supply and purpose of use.
 Summary 
Changes to UK demographics, with the most notable 
changes being increased life expectancy leading to 
an increasingly ageing population, mean increasing 
numbers of people will be affected by both dementia and 
visual impairment (VI). Various conditions cause VI in 
the elderly population, although cases can be 
prevented or treated with early detection and 
correct management. Optometrists frequently 
encounter patients with dementia during primary 
care eye examinations conducted in both practice and 
domiciliary settings, and in the hospital eye service. 
The PrOVIDe study, led by the College of 
Optometrists, used a multidisciplinary approach to 
investigate the prevalence of VI using eye examination 
data and qualitative data on the attitudes and 
experiences of people with dementia, carers and 
optometrists. Results from the PrOVIDe study show it 
is possible for optometrists to conduct key components 
of the eye examination on more than 80% of people 
with dementia. Tailoring the eye examination and 
spectacle dispensing is necessary to meet the needs of 
patients with dementia. This paper provides practical 
advice for optometrists examining patients with 
dementia.
Acknowledgements
We are most grateful to The Outside Clinic head office 
staff and their team of research optometrists for their 
outstanding support throughout our study.
Recruitment was made possible through the tireless efforts 
of the DeNDRoN (Dementia and Neurodegenerative 
Diseases Research Network) recruitment teams.
This project was funded by the National Institute for 
Health Research (Health Services and Delivery Research 
programme) (project number 11/2000/13). The views and 
opinions expressed herein are those of the authors and do 
not necessarily reflect those of the Health Services and 
Delivery Research, National Institute for Health Research, 
NHS or the Department of Health.
■■References
■■ Access Economics (2009) Future Sight Loss UK (1): The Economic 
Impact of Partial Sight and Blindness in the UK Population. 
Available online at: www.rnib.org.uk/sites/default/files/FSUK_
Report.pdf (accessed 30 August 2017)
■■ Alzheimer’s Society (2017) Demography. Available online at: 
https://www.alzheimers.org.uk/info/20091/what_we_think/93/
demography (accessed 30 August 2017)
■■ American Psychiatric Association (2013) Diagnostic and 
Statistical Manual of Mental Disorders (DSM-V). Arlington, USA: 
American Psychiatric Association
■■ Armstrong R, Kergoat H (2015) Oculo-visual changes and 
clinical considerations affecting older patients with dementia. 
Ophthalm Physiol Optics 35, 352–76
■■ Bowen M, Edgar DF, Hancock B et al. (2016) The Prevalence 
of Visual Impairment in People with Dementia (the PrOVIDe 
study): a cross-sectional study of people aged 60–89 years with 
dementia and qualitative exploration of individual, carer and 
professional perspectives. Health Serv Deliv Res 4, 1–200
■■ Bunce C, Wormald R (2006) Leading causes of certification for 
blindness and partial sight in England and Wales. BMC Public 
Health 6, 58
■■ Chandra SR, Issac TG (2014) Neurodegeneration and mirror 
image agnosia. North Am J Med Sci 6, 472–7
■■ Cogan DG (1985) Visual disturbances with focal progressive 
dementing disease. Am J Ophthalmol 100, 68–72
■■ College of Optometrists (2014a) Guidance for Professional 
Practice. Available online at: http://guidance.college- 
optometrists.org/guidance-contents/knowledge-skills-and-
performance-domain/ (accessed 18 October 2017)
■■ College of Optometrists (2014b) Examining Patients with 
Dementia or Other Acquired Cognitive Impairment. Available 
online at: http://guidance.college-optometrists.org/guidance-
content s/knowledge -sk i l l s-and-per formance - domain/
examining-patients-with-dementia/#open:91,93,94 (accessed 
18 October 2017)
■■ College of Optometrists (2014c) The Domiciliary Eye 
Examination. Available online at: http://guidance.college-
o p t o m e t r i s t s . o r g / g u i d a n c e - c o n t e n t s / k n o w l e d g e -
sk i l l s-and- per formance - domain/the - domic i l ia r y- eye -
examination/#open:99 (accessed 18 October 2017)
■■ College of Optometrists (2014d) Consent, Guidance for 
Professional Practice. Available online at: http://guidance.
college-optometrists.org/guidance-contents/communication-
partnership-and-teamwork-domain/consent/#open:196,190,192 
(accessed 18 October 2017)
R Shah et al.
184
■■ College of Optometrists (2014e) Communication, Partnership 
and Teamwork, Guidance for Professional Practice. Available 
online at: http://guidance.college-optometrists.org/guidance-
contents/communication-partnership-and-teamwork-domain/ 
(accessed 18 October 2017)
■■ Deloitte Access Economics (2017) Incidence and Risk of 
Sightloss and Blindness in the UK. Available online at: 
https://www.rnib.org.uk/professionals/knowledge-and-research-
hub/incidence-and-risk-sight-loss-and-blindness-uk (accessed 
18 October 2017).
■■ Department of Health (2017) Certificate of Vision Impairment: 
Explanatory Notes for Consultant Ophthalmologists and 
Hospital Eye Clinic Staff. Available online at: https://www.gov.
uk/government/uploads/system/uploads/attachment_data/
file/637590/CVI_guidance.pdf. (accessed 12 November 2017)
■■ Elliott DB, Howell-Duffy C (2015) ‘Non-tolerances’ and the 
science of prescribing spectacles. Optom Pract 16, 131–44
■■ Elliott DB, Armstrong D, Alderson AJ (2017) Optometric 
interventions to help prevent dizziness and falls, particularly in 
patients with visual impairment. Optom Pract 18, 111–18
■■ Evans BJ, Rowlands G (2004) Correctable visual impairment 
in older people: a major unmet need. Ophthalm Physiol Optics 
24, 161–80
■■ Evans J, Wormald R (2011) Prevalence and Causes of Blindness 
and Low Vision in the UK from 2010 to 2020: Modelling the Impact 
of Incorporating Estimates of Vision Loss in Non-Community 
Dwelling Adults. London: Vision 2020 UK
■■ Hancock B, Shah R, Edgar DF et al. (2015) A proposal for a 
UK dementia eye care pathway. Optom Pract 16, 71–6
■■ Health and Social Care Information Centre (2016) General 
Ophthalmic Services, Activity Statistics England, 2015–16. 
Available online at: http://content.digital.nhs.uk/catalogue/
PUB21111/gene-opht-serv-acti-eng-year-end-mar-16-rep.pdf
■■ Jonas JB, Aung T, Bourne RR, et al. (2017) Glaucoma. Lancet 
6736, 1–11
■■ Jones R, Martin S (2007) Dementia and serious sight loss. 
Dementia 11, 1–20
■■ Matthews FE, Arthur A, Barnes LE, et al. (2013) A two-decade 
comparison of prevalence of dementia in individuals aged 
65 years and older from three geographical areas of England: 
results of the Cognitive Function and Ageing Study I and II. 
Lancet 382, 1405–12
■■ Mendez MF, Mendez MA, Martin R et al. (1990) Complex visual 
disturbances in Alzheimer’s disease. Neurology 40, 439–43
■■ National Eye Institute (2017) All Vision Impairment. Available 
online at: https://nei.nih.gov/eyedata/vision_impaired (accessed 
18 October 2017)
■■ Optical Confederation (2015) Sight Tests at Home. Available 
online at: http://www.opticalconfederation.org.uk/downloads/
guidance/sighttestsathome2016.pdf
■■ Pakrou N, Gray T, Mills R et al. (2008) Clinical comparison 
of the Icare tonometer and Goldmann applanation tonometry. 
J Glaucoma 17, 43–7
■■ Prince M, Knapp M, Guerchet M et al. (2014) Dementia UK: Update. 
Available online at: www.cfas.ac.uk/files/2015/07/P326_AS_ 
Dementia_Report_WEB2.pdf 
■■ Rashid K, Sheppard AL (2013) Domiciliary eye care – the 
practitioner’s perspective. Optom Today 15 November
■■ RNIB (2013) Sight Loss UK 2013. The latest evidence, pp. 1–36. 
Available online at: http://www.rnib.org.uk/knowledge-and-
research-hub/research-reports/general-research/sight-loss-
UK-2012
■■ RNIB and Age UK (2015) Improving Later Life for People with 
Sight Loss. Available online at: https://www.rnib.org.uk/sites/
default/files/ENG091524_JOINT_SENIMAR_REPORT_V3.pdf 
(accessed 18 October 2017)
■■ Rudnicka AR, Mt.-Isa S, Owen CG et al. (2006) Variations 
in primary open-angle glaucoma prevalence by age, gender, 
and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 
47, 4254–61
CET multiple choice questions
This article has been approved for one non-interactive 
point under the GOC’s Enhanced CET Scheme. The reference 
and relevant competencies are stated at the head of the 
article. To gain your point visit the College’s website 
www.college-optometrists.org/oip and complete the multiple 
choice questions online. The deadline for completion is 
31 January 2019. Please note that the answers that you will 
find online are not presented in the same order as in the 
questions below, to comply with GOC requirements.
1. What is the UK prevalence of dementia in people aged 
over 95 years?
• 1.7%
• 4%
• 20%
• 40%
2. How many people in the UK are affected by 
Alzheimer’s disease?
• 150 000
• 520 000
• 1.64 million
• 3.5 million
3. Which one of the following approaches is most 
appropriate when a person with dementia refuses to 
wear spectacles?
• Fit contact lenses
• Make things bigger, brighter and bolder
• Use a cord to keep spectacles in place
• Use labels so it is clear which spectacles to use
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4. In what proportion of people who took part in the 
PrOVIDe study was it possible to measure distance 
visual acuity successfully?
• 43.2%
• 53.2%
• 83.2%
• 93.2%
5. Capacity to consent in England is governed by which act?
• Accessible Information Standard (2016)
• Data Protection Act (1998)
• Equality Act (2010)
• Mental Capacity Act (2005)
6. What proportion of people with dementia were 
successfully able to undertake the key elements of an eye 
examination as found by the PrOVIDe study?
• 20%
• 40%
• 60%
• 80%
 CPD exercise
After reading this article, can you identify areas in which 
your knowledge of dementia and optometry has been 
enhanced? 
How do you feel you can use this knowledge to offer 
better patient advice?
Are there any areas you still feel you need to study and 
how might you do this?
Which areas outlined in this article would you benefit 
from reading in more depth, and why?
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